A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD
Clicks: 74
ID: 272435
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
20.7
/100
69 views
10 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce these symptoms as well as those of ADHD.
| Reference Key |
adler2021thea
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lenard A. Adler;Terry L. Leon;Taylor M. Sardoff;Beth Krone;Stephen V. Faraone;Michael J. Silverstein;Jeffrey H. Newcorn; |
| Journal | the journal of clinical psychiatry |
| Year | 2021 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.